TREM2, a receptor on the surface of macrophages, could play an important role in atherosclerosis
A publication in Nature Cardiovascular Research from the University Hospital Würzburg (UKW) and the Medical University of Vienna investigates the mechanisms by which the receptor TREM2 affects atherosclerosis and a possible therapeutic approach using an agonistic TREM2 antibody.
from Pressemitteilungen – idw – Informationsdienst Wissenschaft https://ift.tt/vA5tdj7
Martin Empting works towards the development of new active substances that can be used to treat bacterial and viral infections. He has now been awarded the Young Medicinal Chemist in Academia Prize by the European Federation of Medicinal Chemistry (EFMC) as a runner-up. This prize is aimed at young chemists who are pursuing a career in academic research.
Martin Empting works towards the development of new active substances that can be used to treat bacterial and viral infections. He has now been awarded the Young Medicinal Chemist in Academia Prize by the European Federation of Medicinal Chemistry (EFMC) as a runner-up. This prize is aimed at young chemists who are pursuing a career in academic research.